Hand-foot-skin reaction of grade  ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC

Conclusions Our study demonstrated that 2HFSR60, with the best discriminatory ability compared to currently available definitions of sorafenib-related adverse events, could be the optimal clinical marker to identify sorafenib responders with decreased risk of death by half.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research